CN105828831A - 新型肽组合物 - Google Patents

新型肽组合物 Download PDF

Info

Publication number
CN105828831A
CN105828831A CN201480066852.9A CN201480066852A CN105828831A CN 105828831 A CN105828831 A CN 105828831A CN 201480066852 A CN201480066852 A CN 201480066852A CN 105828831 A CN105828831 A CN 105828831A
Authority
CN
China
Prior art keywords
peptide
body weight
xaa
pharmaceutical composition
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480066852.9A
Other languages
English (en)
Chinese (zh)
Inventor
R·弗兰克林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tarix Pharmaceuticals Ltd
Original Assignee
Tarix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tarix Pharmaceuticals Ltd filed Critical Tarix Pharmaceuticals Ltd
Publication of CN105828831A publication Critical patent/CN105828831A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CN201480066852.9A 2013-10-11 2014-10-01 新型肽组合物 Pending CN105828831A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361890056P 2013-10-11 2013-10-11
US61/890,056 2013-10-11
US201461940095P 2014-02-14 2014-02-14
US61/940,095 2014-02-14
PCT/US2014/058646 WO2015054006A2 (en) 2013-10-11 2014-10-01 Novel peptide compositions

Publications (1)

Publication Number Publication Date
CN105828831A true CN105828831A (zh) 2016-08-03

Family

ID=52813728

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480066852.9A Pending CN105828831A (zh) 2013-10-11 2014-10-01 新型肽组合物

Country Status (13)

Country Link
EP (1) EP3054967A4 (https=)
JP (1) JP2017501967A (https=)
KR (1) KR20160065969A (https=)
CN (1) CN105828831A (https=)
AU (1) AU2014332346B2 (https=)
BR (1) BR112016007816A2 (https=)
CA (1) CA2926641A1 (https=)
CL (1) CL2016000836A1 (https=)
IL (1) IL244956B (https=)
MX (1) MX2016004660A (https=)
RU (1) RU2016112931A (https=)
SG (1) SG11201602661PA (https=)
WO (1) WO2015054006A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110520162A (zh) * 2017-02-16 2019-11-29 凯尔格恩有限公司 水杨酸和肽的结合体

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017150327A1 (ja) * 2016-03-03 2017-09-08 不二製油グループ本社株式会社 神経栄養因子の脳内分泌促進するための食品添加用組成物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042561A2 (en) * 2003-10-31 2005-05-12 Neuren Pharmaceuticals Limited Neural regeneration peptides and methods of use
WO2007011595A2 (en) * 2005-07-15 2007-01-25 Neuren Pharmaceuticals Limited Neural regeneration peptides and antioxidants protect neurons from degeneration
US20130210726A1 (en) * 2012-02-10 2013-08-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of peripheral vascular disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244946A (en) 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
US4305872A (en) 1979-10-19 1981-12-15 Kenneth Wingrove Polypeptide derivatives
US4316891A (en) 1980-06-14 1982-02-23 The Salk Institute For Biological Studies Extended N-terminal somatostatin
US6031072A (en) 1996-07-12 2000-02-29 Mcgill University Compounds and methods for modulating cell adhesion
US20020168761A1 (en) 2000-01-24 2002-11-14 Gour Barbara J. Peptidomimetic modulators of cell adhesion
EP1572887A4 (en) * 2001-08-24 2008-12-24 Neuren Pharmaceuticals Ltd NERVE REGENERATING PEPTIDE AND METHOD FOR THEIR USE IN THE TREATMENT OF A BRAIN DAMAGE
US7563862B2 (en) 2001-08-24 2009-07-21 Neuren Pharmaceuticals Limited Neural regeneration peptides and methods for their use in treatment of brain damage
WO2004058807A2 (en) * 2002-12-24 2004-07-15 Algonomics N.V. Mhc class i restricted t-cell stimulating peptides from hepatitis b virus
JP2013532172A (ja) * 2010-07-09 2013-08-15 ダナ ファーバー キャンサー インスティテュート インコーポレイテッド 安定化したインスリン分泌促進ペプチド及び使用方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042561A2 (en) * 2003-10-31 2005-05-12 Neuren Pharmaceuticals Limited Neural regeneration peptides and methods of use
WO2007011595A2 (en) * 2005-07-15 2007-01-25 Neuren Pharmaceuticals Limited Neural regeneration peptides and antioxidants protect neurons from degeneration
US20130210726A1 (en) * 2012-02-10 2013-08-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of peripheral vascular disease

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110520162A (zh) * 2017-02-16 2019-11-29 凯尔格恩有限公司 水杨酸和肽的结合体
CN110520162B (zh) * 2017-02-16 2023-02-17 凯尔格恩有限公司 水杨酸和肽的结合体

Also Published As

Publication number Publication date
EP3054967A4 (en) 2017-04-19
AU2014332346A1 (en) 2016-05-05
CA2926641A1 (en) 2015-04-16
RU2016112931A3 (https=) 2018-06-20
RU2016112931A (ru) 2017-11-16
WO2015054006A3 (en) 2015-06-04
WO2015054006A2 (en) 2015-04-16
EP3054967A2 (en) 2016-08-17
SG11201602661PA (en) 2016-05-30
AU2014332346B2 (en) 2019-01-24
BR112016007816A2 (pt) 2017-12-05
CL2016000836A1 (es) 2016-09-16
IL244956B (en) 2019-10-31
MX2016004660A (es) 2016-11-14
IL244956A0 (en) 2016-05-31
JP2017501967A (ja) 2017-01-19
KR20160065969A (ko) 2016-06-09

Similar Documents

Publication Publication Date Title
US9511055B2 (en) Angiotensin in treating brain conditions
US20180050079A1 (en) Angiotensin peptides in treating marfan syndrome and related disorders
US20180221433A1 (en) Angiotensins in muscular dystrophy
US9333233B2 (en) Methods and compositions for the delayed treatment of stroke
CN105828831A (zh) 新型肽组合物
US20160296591A1 (en) Compositions and methods for treatment of bdnf-related conditions
US9133241B2 (en) Peptide compositions
WO2025122594A1 (en) Improved methods and compositions for the treatment of pemphigus or pemphigoid disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160803

WD01 Invention patent application deemed withdrawn after publication